
    
      The number of patient is eighty-four. Patients were randomly assigned either a Bonviva
      tablet(150mg Ibandronate, qd) first, DP-R206(150mg Ibandronate / 24,000 IU Vitamin D3 complex
      tablet, qd) Second or DP-R206(150mg Ibandronate / 24,000 IU Vitamin D3 complex tablet, qd)
      first, Bonviva tablet(150mg Ibandronate, qd) second.
    
  